Nucleasemediated

Nuclease-mediated refers to processes and technologies in which nucleases—enzymes that cleave nucleic acids—drive biological or experimental outcomes. Nucleases can target DNA or RNA and are categorized as endonucleases that cut within a nucleic acid strand or exonucleases that remove nucleotides from ends. In nature, nucleases participate in DNA repair, recombination, RNA processing, and defense against invading genetic elements, including restriction endonucleases and various RNases. In research and biotechnology, programmable nucleases enable targeted manipulation of genetic material. By creating a DNA break at a chosen site, the cell’s repair pathways—non-homologous end joining or homology-directed repair—can introduce mutations, restore function, or incorporate new sequences. RNA-targeting nucleases likewise regulate transcripts or process RNA molecules.

Prominent tools include CRISPR-Cas systems, zinc-finger nucleases, and TAL effector nucleases, which provide sequence-specific DNA cleavage, and RNA-targeting enzymes such as certain RNases and Dicer-related pathways used in RNA interference and processing. Applications encompass functional genomics, model organism research, therapeutic development, and diagnostics, including nucleic acid detection methods that rely on nuclease activity. Limitations include off-target effects, delivery and expression challenges in cells or organisms, potential immune responses, and ethical or regulatory considerations for clinical use. Ongoing work focuses on improving specificity, efficiency, and safety while expanding the range of substrates and contexts in which nuclease-mediated approaches can be applied.